Ryan Nelson

6.2k total citations · 1 hit paper
9 papers, 4.7k citations indexed

About

Ryan Nelson is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Ryan Nelson has authored 9 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Ryan Nelson's work include Pancreatic and Hepatic Oncology Research (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and RNA Interference and Gene Delivery (2 papers). Ryan Nelson is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and RNA Interference and Gene Delivery (2 papers). Ryan Nelson collaborates with scholars based in United States, United Kingdom and Netherlands. Ryan Nelson's co-authors include Daniel D. Von Hoff, Anna Maria Storniolo, John Sahl Andersen, Connie Stephens, Manuel Modiano, F. Andrew Dorr, Howard A. Burris, Mace L. Rothenberg, Peter G. Tarassoff and Malcolm J. Moore and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Heart.

In The Last Decade

Ryan Nelson

9 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

1997 4.6k citations Howard A. Burris, Malcolm J. Moore et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryan Nelson United States	6	3.9k	1.4k	1.1k	1.1k	981	9	4.7k
Connie Stephens United States	7	3.9k 1.0×	1.4k 1.0×	1.1k 1.0×	1.1k 1.0×	1.0k 1.0×	9	4.9k
Denis Péré-Vergé France	6	5.0k 1.3×	1.8k 1.3×	1.5k 1.4×	1.3k 1.2×	964 1.0×	11	5.6k
Faiza Khemissa-Akouz France	3	5.0k 1.3×	1.8k 1.3×	1.5k 1.4×	1.3k 1.2×	961 1.0×	5	5.5k
Stefan Boeck Germany	36	3.4k 0.9×	1.2k 0.8×	1.2k 1.1×	852 0.8×	805 0.8×	145	4.3k
M. Christine Cripps Canada	12	4.5k 1.2×	1.5k 1.1×	1.3k 1.1×	1.2k 1.2×	1.1k 1.2×	26	5.5k
P. Murawa Poland	16	3.0k 0.8×	1.1k 0.8×	1.2k 1.0×	605 0.6×	890 0.9×	47	4.1k
Andrew H. Ko United States	35	3.8k 1.0×	1.7k 1.2×	963 0.9×	626 0.6×	1.4k 1.5×	150	4.9k
C. Montoto-Grillot France	11	5.8k 1.5×	1.8k 1.3×	1.9k 1.7×	1.3k 1.2×	999 1.0×	19	6.6k
David Walde Canada	16	3.7k 1.0×	1.0k 0.7×	1.4k 1.3×	673 0.6×	1.0k 1.0×	22	4.8k
H. Au Canada	13	2.9k 0.8×	979 0.7×	1.1k 1.0×	597 0.6×	681 0.7×	23	3.5k

Countries citing papers authored by Ryan Nelson

Since Specialization

Citations

This map shows the geographic impact of Ryan Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Nelson more than expected).

Fields of papers citing papers by Ryan Nelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Nelson. The network helps show where Ryan Nelson may publish in the future.

Co-authorship network of co-authors of Ryan Nelson

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Nelson. A scholar is included among the top collaborators of Ryan Nelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Nelson. Ryan Nelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Fens, Marcel H.A.M., Ryan Nelson, Anja Krippner‐Heidenreich, et al.. (2023). Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid Nanoparticles. Pharmaceutics. 15(6). 1603–1603. 16 indexed citations

2.

Burris, Howard A., Malcolm J. Moore, John Sahl Andersen, et al.. (2023). Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial. Journal of Clinical Oncology. 41(36). 5482–5492. 11 indexed citations

3.

Buskin, Adriana, Emma Scott, Ryan Nelson, et al.. (2023). Engineering prostate cancer in vitro: what does it take?. Oncogene. 42(32). 2417–2427. 7 indexed citations

4.

Nelson, Ryan, et al.. (2021). PCN77 Cost-effectiveness analysis of adjuvant FOLFIRINOX vs Gemcitabine/Nab-paclitaxel for resected pancreatic cancer in the United States: based on PRODIGE and APACT trial. Value in Health. 24. S33–S33. 1 indexed citations

5.

Nelson, Ryan, et al.. (2020). Tissue Factor Oligomerization in Living Cells Using Förster Resonance Energy Transfer. Microscopy and Microanalysis. 26(S2). 828–829. 2 indexed citations

6.

Cheng, Yan, et al.. (2015). Predicting Human Immunodeficiency Virus Veterans’ Adherence to Antiretroviral agents via optimal data analysis. Value in Health. 18(3). A241–A241. 1 indexed citations

7.

Nelson, Ryan, et al.. (2011). Overestimation of the effects of adherence on outcomes: a case study in healthy user bias and hypertension. Heart. 97(22). 1862–1869. 31 indexed citations

8.

Nelson, Ryan, et al.. (2011). Validated risk rule using computerized data to identify males at high risk for fracture. Osteoporosis International. 23(3). 1017–1027. 11 indexed citations

9.

Burris, Howard A., Malcolm J. Moore, John Sahl Andersen, et al.. (1997). Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.. Journal of Clinical Oncology. 15(6). 2403–2413. 4630 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact